The effect of tibolone on fat mass, fat-free mass, and total body water in postmenopausal women

被引:31
作者
Meeuwsen, IB [1 ]
Samson, MM [1 ]
Duursma, SA [1 ]
Verhaar, HJ [1 ]
机构
[1] Univ Utrecht, Med Ctr, Dept Geriatr Med, Mobil Lab, NL-3508 GA Utrecht, Netherlands
关键词
D O I
10.1210/en.142.11.4813
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Changes in body composition occur around the menopausal transition. The major characteristics are a decline in fat-free mass and an increase in body fat as a percentage of body weight. These alterations might be affected by age only or by menopause-related changes in hormone concentration. In this study the effects of tibolone, a tissue-specific compound with favorable effects on bone, vagina, and climacteric symptoms, were determined on body composition using bioelectrical impedance analysis. The focus was especially on fat mass, fat-free mass, and total body water in a group of 85 healthy women (mean +/- SD age, 54.2 +/- 4.7 yr), between 1-15 yr postmenopausal. Participants were randomly assigned to either tibolone (2.5 mg; n = 42) or identically appearing placebo tablets (n = 43) daily for 12 months. All analyses were based on the intent to treat group and last visit. Compared with placebo, tibolone significantly increased fat-free mass by 0.85 kg (P = 0.003) and total body water by 0.78 liter (P = 0.001). No significant difference was observed on the fat mass parameter (P = 0.16). From these results it can be concluded that tibolone may counteract the postmenopausal changes in body composition.
引用
收藏
页码:4813 / 4817
页数:5
相关论文
共 44 条
  • [1] EFFECTS OF INTERSCAPULAR BROWN ADIPOSE-TISSUE DENERVATION ON BODY-WEIGHT AND ENERGY-METABOLISM IN OVARIECTOMIZED AND ESTRADIOL-TREATED RATS
    BARTNESS, TJ
    WADE, GN
    [J]. BEHAVIORAL NEUROSCIENCE, 1984, 98 (04) : 674 - 685
  • [2] BIOELECTRIC IMPEDANCE PHASE-ANGLE AND BODY-COMPOSITION
    BAUMGARTNER, RN
    CHUMLEA, WC
    ROCHE, AF
    [J]. AMERICAN JOURNAL OF CLINICAL NUTRITION, 1988, 48 (01) : 16 - 23
  • [3] Bergström A, 2001, INT J CANCER, V91, P421, DOI 10.1002/1097-0215(200002)9999:9999&lt
  • [4] ::AID-IJC1053&gt
  • [5] 3.0.CO
  • [6] 2-T
  • [7] Bjorntorp P, 1993, Obes Res, V1, P206
  • [8] BRUMMER RJM, 1993, ACTA ENDOCRINOL-COP, V128, P30
  • [9] TREATMENT WITH ALPHA-HELICAL-CRF(9-41) PREVENTS THE ANORECTIC EFFECT OF 17-BETA-ESTRADIOL
    DAGNAULT, A
    OUERGHI, D
    RICHARD, D
    [J]. BRAIN RESEARCH BULLETIN, 1993, 32 (06) : 689 - 692
  • [10] DEVISSER J, 1984, ARZNEIMITTELFORSCH, V34-2, P1010